Vai al contenuto principale della pagina
| Titolo: |
Examining Emergent Biosolutions' failure to protect public health and public funds : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021
|
| Pubblicazione: | Washington : , : U.S. Government Publishing Office, , 2021 |
| Descrizione fisica: | 1 online resource (iii, 44 pages) |
| Disciplina: | 4.OV 2:117-23 |
| Soggetto topico: | COVID-19 (Disease) - Vaccination - United States |
| COVID-19 Pandemic, 2020- - United States | |
| Vaccines industry - Government policy - United States | |
| Vaccines industry - Subsidies - United States | |
| Vaccines - United States | |
| COVID-19 (Disease) - Vaccination | |
| Vaccines industry - Government policy | |
| Vaccines industry - Subsidies | |
| Soggetto geografico: | United States |
| Soggetto genere / forma: | Legislative hearings. |
| Note generali: | Access ID (govinfo): CHRG-117hhrg44686. |
| "Serial no. 117-23." | |
| Altri titoli varianti: | Examining Emergent Biosolutions' failure to protect public health and public funds |
| Titolo autorizzato: | Examining Emergent Biosolutions' failure to protect public health and public funds ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910716651603321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |